Free Access
Med Sci (Paris)
Volume 28, Number 11, Novembre 2012
Page(s) 951 - 957
Section M/S Revues
Published online 12 November 2012
  1. Saulnier-Blache JS. L’acide lysophosphatidique : un phospholipide bioactif. Med Sci (Paris) 2004 ; 20 : 799–803. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Lee MJ, Van Brocklyn JR, Thangada S, et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998 ; 279 : 1552–1555. [CrossRef] [PubMed] [Google Scholar]
  3. Liu Y, Wada R, Yamashita T, et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 2000 ; 106 : 951–961. [CrossRef] [PubMed] [Google Scholar]
  4. MacLennan AJ, Carney PR, Zhu WJ, et al. An essential role for the H218/AGR16/Edg-5/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability. Eur J Neurosci 2001 ; 14 : 203–209. [CrossRef] [PubMed] [Google Scholar]
  5. Kono M, Belyantseva IA, Skoura A, et al. Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem 2007 ; 282 : 10690–10696. [CrossRef] [PubMed] [Google Scholar]
  6. Schulze T, Golfier S, Tabeling C, et al. Sphingosine-1-phosphate receptor 4 (S1P) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model. FASEB J 2011 ; 25 : 4024–4036. [CrossRef] [PubMed] [Google Scholar]
  7. Lee MJ, Thangada S, Claffey KP, et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999 ; 99 : 301–312. [CrossRef] [PubMed] [Google Scholar]
  8. Singleton PA, Dudek SM, Ma SF, Garcia JG. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J Biol Chem 2006 ; 281 : 34381–34393. [CrossRef] [PubMed] [Google Scholar]
  9. Sanchez T, Skoura A, Wu MT, et al. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol 2007 ; 27 : 1312–1318. [CrossRef] [PubMed] [Google Scholar]
  10. Niessen F, Furlan-Freguia C, Fernandez JA, et al. Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality. Blood 2009 ; 113 : 2859–2866. [CrossRef] [PubMed] [Google Scholar]
  11. Chae SS, Paik JH, Furneaux H, Hla T. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest 2004 ; 114 : 1082–1089. [PubMed] [Google Scholar]
  12. Salomone S, Potts EM, Tyndall S, et al. Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. Br J Pharmacol 2008 ; 153 : 140–147. [CrossRef] [PubMed] [Google Scholar]
  13. Szczepaniak WS, Pitt BR, McVerry BJ. S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate. Am J Physiol Lung Cell Mol Physiol 2010 ; 299 : L137–L145. [CrossRef] [PubMed] [Google Scholar]
  14. Nofer JR, van der Giet M, Tolle M, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 2004 ; 113 : 569–581. [PubMed] [Google Scholar]
  15. Theilmeier G, Schmidt C, Herrmann J, et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 2006 ; 114 : 1403–1409. [CrossRef] [PubMed] [Google Scholar]
  16. Whetzel AM, Bolick DT, Srinivasan S, et al. Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor. Circ Res 2006 ; 99 : 731–739. [CrossRef] [PubMed] [Google Scholar]
  17. Wang F, Okamoto Y, Inoki I, et al. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. J Clin Invest 2010 ; 120 : 3979–3995. [CrossRef] [PubMed] [Google Scholar]
  18. Zhang J, Honbo N, Goetzl EJ, et al. Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol 2007 ; 293 : H3150–H3158. [CrossRef] [PubMed] [Google Scholar]
  19. Vessey DA, Li L, Kelley M, Karliner JS. Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia. Biochem Biophys Res Commun 2008 ; 375 : 425–429. [CrossRef] [PubMed] [Google Scholar]
  20. Means CK, Xiao CY, Li Z, et al. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2007 ; 292 : H2944–H2951. [CrossRef] [PubMed] [Google Scholar]
  21. Mandala S, Hajdu R, Bergstrom J, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002 ; 296 : 346–349. [CrossRef] [PubMed] [Google Scholar]
  22. Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004 ; 427 : 355–360. [CrossRef] [PubMed] [Google Scholar]
  23. Allende ML, Dreier JL, Mandala S, Proia RL. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem 2004 ; 279 : 15396–15401. [CrossRef] [PubMed] [Google Scholar]
  24. Allende ML, Tuymetova G, Lee BG, et al. S1P1 receptor directs the release of immature B cells from bone marrow into blood. J Exp Med 2010 ; 207 : 1113–1124. [CrossRef] [PubMed] [Google Scholar]
  25. Nofer JR, Bot M, Brodde M, et al. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2007 ; 115 : 501–508. [CrossRef] [PubMed] [Google Scholar]
  26. Hughes JE, Srinivasan S, Lynch KR, et al. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ Res 2008 ; 102 : 950–958. [CrossRef] [PubMed] [Google Scholar]
  27. Weigert A, Johann AM, von Knethen A, et al. Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. Blood 2006 ; 108 : 1635–1642. [CrossRef] [PubMed] [Google Scholar]
  28. Mizugishi K, Yamashita T, Olivera A, et al. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 2005 ; 25 : 11113–11121. [CrossRef] [PubMed] [Google Scholar]
  29. Jaillard C, Harrison S, Stankoff B, et al. Edg8/S1P5 : an oligodendroglial receptor with dual function on process retraction and cell survival. J Neurosci 2005 ; 25 : 1459–1469. [CrossRef] [PubMed] [Google Scholar]
  30. Novgorodov AS, El-Alwani M, Bielawski J, et al. Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J 2007 ; 21 : 1503–1514. [CrossRef] [PubMed] [Google Scholar]
  31. Fujino M, Funeshima N, Kitazawa Y, et al. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J Pharmacol Exp Ther 2003 ; 305 : 70–77. [CrossRef] [PubMed] [Google Scholar]
  32. Webb M, Tham CS, Lin FF, et al. Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J Neuroimmunol 2004 ; 153 : 108–121. [CrossRef] [PubMed] [Google Scholar]
  33. Rausch M, Hiestand P, Foster CA, et al. Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking : clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 2004 ; 20 : 16–24. [CrossRef] [PubMed] [Google Scholar]
  34. Jung CG, Kim HJ, Miron VE, et al. Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia 2007 ; 55 : 1656–1667. [CrossRef] [PubMed] [Google Scholar]
  35. Mege JL, Capo C. La polarisation des macrophages, le nœud gordien des infections bactériennes. Med Sci (Paris) 2010 ; 26 : 83–88. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.